Legis Daily

Discounted Drugs for Clinical Trials Act

USA117th CongressHR-7472| House 
| Updated: 4/8/2022
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (5)
Mark DeSaulnier (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Peter Welch (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Discounted Drugs for Clinical Trials Act This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 7, 2022

Latest Companion Bill Action

S 117-4053
Introduced in Senate
Apr 7, 2022
Introduced in House
Apr 7, 2022
Referred to the House Committee on Energy and Commerce.
Apr 8, 2022
Referred to the Subcommittee on Health.
  • April 7, 2022

    Latest Companion Bill Action

    S 117-4053
    Introduced in Senate


  • April 7, 2022
    Introduced in House


  • April 7, 2022
    Referred to the House Committee on Energy and Commerce.


  • April 8, 2022
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 117-4053: Discounted Drugs for Clinical Trials Act
  • S 117-4026: Discounted Drugs for Clinical Trials Act

Discounted Drugs for Clinical Trials Act

USA117th CongressHR-7472| House 
| Updated: 4/8/2022
Discounted Drugs for Clinical Trials Act This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Apr 7, 2022

Latest Companion Bill Action

S 117-4053
Introduced in Senate
Apr 7, 2022
Introduced in House
Apr 7, 2022
Referred to the House Committee on Energy and Commerce.
Apr 8, 2022
Referred to the Subcommittee on Health.
  • April 7, 2022

    Latest Companion Bill Action

    S 117-4053
    Introduced in Senate


  • April 7, 2022
    Introduced in House


  • April 7, 2022
    Referred to the House Committee on Energy and Commerce.


  • April 8, 2022
    Referred to the Subcommittee on Health.
Carolyn B. Maloney

Carolyn B. Maloney

Democratic Representative

New York

Cosponsors (5)
Mark DeSaulnier (Democratic)Jamie Raskin (Democratic)Janice D. Schakowsky (Democratic)Peter Welch (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-4053: Discounted Drugs for Clinical Trials Act
  • S 117-4026: Discounted Drugs for Clinical Trials Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted